Publications & Works

Articles 94
All (94)
SCI-E, SSCI, AHCI (76)
SCI-E, SSCI, AHCI, ESCI (86)
ESCI (10)
Scopus (86)
TRDizin (20)
Papers Presented at Peer-Reviewed Scientific Conferences 58

1. Multipl Miyelom'da Genetik Karmaşa: Optik Genom Haritalamanın Yeri

12. Hematolojik Onkoloji Kongresi, KKTC, Turkey, 02 October 2025, pp.134-137, (Summary Text)

5. Bir Taşla İki Kuş: Akalabrutinib ile KLL ve Anjiyoödem Kontrolü

51. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October 2025, pp.337-338, (Summary Text)

8. Multipl Myelomda lenalidomidin beklenmeyen yüzü: Lökositoklastik vaskülit

İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2025, Sapanca/Sakarya, Turkey, 10 April 2025, pp.58, (Summary Text)

11. Optical Genome Mapping in Newly Diagnosed Chronic Lymphocytic Leukemia

66th ASH Annual Meeting and Exposition, San Diego, CA, United States Of America, 7 - 10 December 2024, pp.6758, (Summary Text)

13. Multipl miyelomda kemik iliği fibrozisinin ekstramedüller hastalık ile ilişkisi

25. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 8 - 12 November 2023, pp.77-78, (Full Text) Sustainable Development

14. The Effect of T-Lymphocyte Subgroups at Diagnosis on the Prognosis of Chronic Lymphocytic Leukemia (CLL)

Proceedings of the Society of Hematologic Oncology 2023 Annual Meeting, Houston, United States Of America, 6 - 09 September 2023, (Summary Text)

15. The relationship of bone marrow fibrosis with extramedullary disease in multiple myeloma

28th Congress of the European Hematology Association (EHA 2023), Frankfurt, Germany, 08 June 2023, pp.1776, (Summary Text)

17. Covid vaccination associated acquired thrombotic thrombocytopenic purpura

Soho 2023 Türkiye Tenth Annual Meeting, İstanbul, Turkey, 05 May 2023, pp.52, (Summary Text)

25. WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?

XIIth Eurasian Hematology-Oncology Congress, İSTANBUL (Hibrit Kongre), Turkey, 10 November 2021, vol.43, pp.96, (Summary Text)

28. A raman tweezer study with single red blood cells for the diagnosis of paroxysmal nocturnal hemoglobinuria

Optical Molecular Probes, Imaging and Drug Delivery, OMP 2021 - Part of Biophotonics Congress: Optics in the Life Sciences 2021, Virtual, Online, United States Of America, 12 - 16 April 2021, (Full Text)

29. Dual-Beam optical Manipulation of Red blood cells for the investigation of paroxysmal nocturnal hemoglobinuria

Optical Manipulation and Its Applications, OMA 2021 - Part of Biophotonics Congress: Optics in the Life Sciences 2021, Virtual, Online, United States Of America, 12 - 16 April 2021, (Full Text)

30. Steroide duyarlı kronik anemisi ve osteosklerozu olan erişkin olguda moleküler tanının klinik izleme etkisi

14. Ulusal Tıbbi Genetik Kongresi (Uluslararası katılımlı), Turkey, 20 - 23 November 2020, pp.37, (Summary Text)

32. MİKROANJİYOPATİK HEMOLİTİK ANEMİNİN GEÇ GELİŞTİĞİ BİR ATİPİK HEMOLİTİK ÜREMİK SENDROM VAKASI

İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri - İnteraktif Güncelleştirme 2020, Sakarya, Turkey, 12 March 2020, pp.165, (Full Text)

33. Evaluation of Patients with PNH Treated By Eculizumab: Real World Data from Turkey

61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America, 7 - 10 December 2019, vol.134, (Summary Text)

36. The Importance of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: A Cohort Study

60th Annual Meeting of the American-Society-of-Hematology (ASH), California, United States Of America, 1 - 04 December 2018, vol.132, (Summary Text)

37. Akut Myeloid Lösemi ve 3q Kromozomal Yeniden Düzenlenmeleri

3. Ulusal Uygulamalı Biyolojik Bilimler Kongresi (UBBK), Eskişehir, Turkey, 3 - 05 May 2018, vol.1, pp.35, (Summary Text)

38. The Whole Exome Analysis and Clinical Relevance in Patients with Atypical Hemolytic Uremic Syndrome

59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 9 - 12 December 2017, vol.130, (Summary Text)

39. RNA sequencing and in silico analysis of Myeloma cells in multiple myeloma patients

XV.Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Fethiye- Muğla, Turkey, 26 - 29 October 2017, pp.108, (Summary Text)

40. Yine yeniden Hodgkin lenfoma olguları: Nüks mü ikincil kanser mi?

43. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017, pp.156, (Summary Text) Sustainable Development

41. Multiple Myeloma hastalarının Myeloma hücrelerinde RNA dizileme ve insilico analizler.

XV. Ulusal Tıbbi Biyoloji ve Genetik Kongresi , Muğla, Turkey, 26 - 29 October 2017, pp.108-109, (Summary Text)

44. USE OF ELTROMBOPAG IN IMMUNE THROMBOCYTOPENIA IN TURKEY

24th Biennial International Congress on Thrombosis / EMLTD Congress, İstanbul, Turkey, 4 - 07 May 2016, vol.141, (Summary Text)

46. Circulating Endothelial Progenitor Cells and Their Relation to Thrombosis in Paroxysmal Nocturnal Hemoglobinuria

57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 5 - 08 December 2015, vol.126, (Summary Text)

47. ACI LDE ZOR VAKALAR ZOR KARARLAR

17. Ulusal İç Hastalıkları Kongresi, Turkey, 14 - 18 October 2015

48. Hasta ortada kalmasın Multidisipliner yaklaşım

"Geleneksel İç Hastalıkları Günleri-İnteraktif Güncelleştirme - 2016", Turkey, 11 - 13 March 2015

49. VAKALARLA ACI LDE KANAMALI HASTAYA YAKLAS IM

16. Ulusal İç Hastalıkları Kongresi, Turkey, 15 - 19 October 2014

50. ZBTB7A AND BCL6 GENES ARE NOT EXPRESSED IN CLL

38th Meeting of the International-Society-of-Oncology-and-BioMarkers (ISOBM), Munchen, Germany, 3 - 08 September 2010, vol.31, (Summary Text)

53. Kronik Lenfositik Lösemili Hastalarda p53 P14ARF ve HDM2 Gen İfade Düzeyleri

XVIII. Ulusal Kanser Kongresi, Antalya, Antalya, Turkey, 21 - 26 April 2009, pp.194, (Full Text) Creative Commons License

54. Does previous interferon use have negative effect on imatinib response in chronic myeloid leukemia (CML)? A single center study.

48th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 9 - 12 December 2006, vol.108, (Summary Text)

55. beta-adducin gene expression is suppressed during megakaryopoiesis.

45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 6 - 09 December 2003, vol.102, (Summary Text)

56. The association of HLA class I antigens and class II alleles with multiple myeloma in Turkey.

45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 6 - 09 December 2003, vol.102, (Summary Text)

57. Differential expression of adducin mRNAs during erythropoiesis.

44th Annual Meeting of the American-Society-of-Hematology, PHILADELPHIA, PENNSYLVANIA, 6 - 10 December 2002, vol.100, (Summary Text)

58. Myeloid/Natural Killer Cell Acute Leukemia: A Case Report

5th Annual Meeting of The European Haematology Association, Birmington, United Kingdom, 25 - 28 June 2000, pp.106, (Full Text)
Metrics

Publication

152

Publication (WoS)

102

Publication (Scopus)

88

Citation (WoS)

1171

H-Index (WoS)

14

Citation (Scopus)

1254

H-Index (Scopus)

14

Citation (Scholar)

4

H-Index (Scholar)

1

Project

2

Thesis Advisory

7

Open Access

14
UN Sustainable Development Goals